Frequently asked questions.
It’s real. Ketamine treatment is an intravenous infusion procedure performed in a specially-equipped medical office by a member of the Luminous team.
It’s not hype. The National Institutes of Health has been studying ketamine’s effect on depression for more than ten years. There is serious scholarly research behind this treatment, which means controlled, double-blind, peer-reviewed studies at major institutions.
Researchers at Yale pioneered this research nearly 20 years ago and published the first major study in 2000. Since then, dozens more ketamine studies have been conducted at Yale and other major institutions including NIH, The VA, Harvard, Johns Hopkins, Mt. Sinai Medical School, Oxford University, and many more around the world.